A Reassuring Mindfulness Study Is Not a Safety Clearance

This is a fictional composite. It is not a description of an actual patient.

When a patient reports feeling worse during treatment, the clinical task is to understand the change, assess risk, and agree on what happens next. A favorable group result cannot do that work for us.

A patient with recurrent depression has been doing better. They enroll in a mindfulness-based cognitive therapy group to help maintain that progress. At the next psychiatric appointment, they describe feeling more distressed after practicing at home. They have begun avoiding the exercises and are reluctant to tell the group leader.

The psychiatrist has just read a reassuring study about mindfulness-based cognitive therapy. The patient has just described an experience that needs attention.

Both belong in the conversation.

An August 20 JAMA Network Open research letter by Goldberg and colleagues reanalyzed individual participant data from nine randomized trials involving 1,258 adults with recurrent major depression in remission or partial remission. It examined depressive-symptom worsening after mindfulness-based cognitive therapy, or MBCT, compared with control conditions.[1]

Worsening was defined using change on the Beck Depression Inventory. Among participants with posttreatment assessments, it occurred in 22.5% of the MBCT group and 33.3% of controls. The primary two-stage analysis did not find a statistically significant difference: odds ratio 0.60, 95% confidence interval 0.34 to 1.08. A one-stage analysis favored MBCT. Neither model showed a significant difference against the active-control subgroup.[1]

That is reassuring evidence within a defined population and outcome. It is not proof that every participant was unharmed. The authors explicitly note that depressive-symptom worsening does not capture the full range of adverse experiences and that the findings may not generalize to acute depression or other clinical populations.[1]

“I felt worse” begins an assessment. It does not tell us, by itself, what changed or why.

The patient might mean a brief period of sadness during an exercise, distress that continues into the evening, a deterioration in everyday functioning, or something they have difficulty naming. Those descriptions call for different follow-up questions. The first job is to get beyond the summary phrase.

Ask the patient to describe one episode in ordinary language. What were they doing? What happened next? How long did it last? What did they stop doing afterward? What helped, if anything? What makes them connect the change with the practice?

These are proposed clinical questions, not a validated adverse-event instrument. Their purpose is to make the report specific enough to discuss and revisit.

It is possible to take the report seriously while remaining uncertain about attribution. A useful response might be: “I want to understand what happened and whether you feel safe continuing. We can decide what to change while we work out the cause.”

That response leaves room for investigation without asking the patient to defend their distress against a journal article.

NCCIH describes MBCT as an integration of mindfulness practices with aspects of cognitive behavioral therapy. Meditation and mindfulness encompass a much wider collection of practices and programs.[2]

In the fictional encounter, the group has a name, but the home practice still needs clarification. Is the patient following the assigned recording? Adding a different app? Practicing for longer than instructed? Following advice from someone outside the treatment team?

A referral labeled “mindfulness” is too imprecise to answer those questions. Ask about the program, instructor, instructions, frequency, and any changes the patient has made. NCCIH specifically advises asking about an instructor's training and experience, discussing complementary approaches with health care providers, and not using them to replace or delay conventional care.[2]

The practical implication is to establish what treatment is being evaluated before deciding that evidence about a named intervention answers the patient's concern.

Safety decisions should not wait for agreement about whether an exercise caused the deterioration.

NICE recommends asking people with depression directly about suicidal ideation and intent. It calls for urgent specialist referral when there is considerable immediate risk to the person or others, and treatment review for marked or prolonged agitation.[3]

For ongoing depression treatment, NICE also recommends monitoring harms and suicidal ideation and reviewing how treatment is working between 2 and 4 weeks of initiation. That routine review window is not a reason to defer an assessment of new concerns.[3]

For the psychiatrist hearing this report, the immediate questions are concrete: What is the patient's current condition? What needs attention now? Who will provide that care? What does the patient understand about obtaining help if things deteriorate?

A literature discussion may inform the eventual formulation. It does not replace today's assessment.

Once urgent needs have been addressed, review the treatment with the patient and, with appropriate permission, the person delivering it. Consider whether to continue, modify, pause, or replace the practice in light of the actual experience, clinical assessment, and patient preference. These are individualized options, not a universal instruction to stop mindfulness treatment.

The coordination conversation should contain the patient's description rather than only a conclusion such as “cannot tolerate mindfulness.” Ask what the instructor observed, whether the experience has been discussed, and what changes are feasible. Establish who will follow up and when.

Do not leave the patient responsible for reconciling two unexplained messages: “the evidence is reassuring” and “tell us if you get worse.” Explain how their report changes the plan, even if the cause remains uncertain.

An agreed review should have a concrete question attached to it. Did the distress persist? Has daily functioning changed? Is the revised approach acceptable to the patient? Are additional assessment or treatment changes needed?

Those questions make the follow-up about the patient's course rather than about whether they completed the assigned practice.

A useful record can distinguish four elements:

This is an editorial documentation framework. It has not been tested by the cited meta-analysis.

Avoid converting uncertainty into an assertion either way. “The patient reports distress after practice; the relationship remains uncertain” is a different statement from “MBCT caused deterioration.” It is also different from “the practice could not have contributed.” Any documentation must reflect what was actually assessed.

The patient in the opening scene needs an explanation they can use: their experience has been heard, the risks have been assessed, and there is an agreed next step. Reassuring evidence belongs in that explanation. It should never be the end of it.

1. Goldberg SB, Simonsson O, Warren FC, et al. Symptom Worsening in Mindfulness-Based Cognitive Therapy. JAMA Network Open. 2026;9(8):e2629946. doi:10.1001/jamanetworkopen.2026.29946. Full main article reviewed, including methods, results, limitations, and disclosures. Supplement not independently reviewed.

2. National Center for Complementary and Integrative Health. Meditation and Mindfulness: Effectiveness and Safety. Public guidance, full page reviewed. Page identifies its content update as June 2022; it is background guidance, not a response to the 2026 study.

3. NICE. Depression in adults: treatment and management, NG222. Recommendations 1.2.8 to 1.2.10 and 1.4.3. Verified against current NICE guideline text on September 5, 2026.

Educational Disclaimer: The Psychiatric Record provides general educational information for psychiatric and mental-health professionals. Content does not constitute medical, legal, regulatory, compliance, billing, or other professional advice; does not establish a standard of care; and is not a substitute for independent professional judgment. Appropriate assessment and treatment depend on the patient, setting, available interventions, evidence, and current authoritative guidance. This article does not recommend starting, continuing, stopping, or changing any medication or treatment for any individual, and it does not clear or contraindicate any mindfulness or psychotherapy program for any person. The patient described is a fictional composite; no individual is depicted.